BioMedWire Stocks

Climate Change is Accelerating the Spread of Infectious Diseases, Experts Warn

Scientists and public health experts are warning that climate change is accelerating the rate at which infectious diseases spread, and policymakers don’t seem to be taking this threat as seriously as they should. 

A sobering example is the 14 million cases of dengue fever that were recorded globally in 2024. This figure was double what had been documented in 2023, 7 million cases. A major contributor to this spike was the El Niño weather that occurred around that time. 

That spike in dengue cases was alarming, and it was also a warning sign that as the planet continued warming up, many more such massive outbreaks of infectious diseases would occur. 

As global warming accelerates, the geography of diseases is shifting. The window within which vectors that spread diseases thrive is becoming wider, and that is exposing a lot more people to the risk of being infected by the diseases spread by those vectors. 

For example, winter frosts used to kill lots of mosquitoes, but as global warming continues, more of these vectors are surviving for longer and spreading malaria. Ticks and rodents that carry disease-causing microbes are also increasing the geographical range within which they survive because of the warming climate. 

Prof. Peng Bi, a public health expert, conducted a study showing that 3.8 billion individuals around the world now face a risk of contracting dengue fever as a result of rising temperatures. His research shows that nearly half of the global population now faces the dengue fever infection risk. 

Extreme weather events, such as droughts and floods, increase the risk of infectious diseases. This explains why cases of diseases like cholera spike after flooding. Additionally, extreme weather events displace people, making it harder for disease surveillance and management to be undertaken. 

Climate extremes also influence respiratory viruses, according to numerous studies. For example, abnormally low or abnormally high levels of humidity have been linked to elevated transmission of flu. 

As global warming continues, it is clear that infectious diseases are going to become more rampant, and public health systems and policymakers need to prepare for these outbreaks. One key proactive measure is in expanding access to accurate diagnostic tools to detect these cases as soon as possible. 

The challenge is that most advanced testing capabilities are concentrated in centralized labs, and this makes those testing services inaccessible where they are most needed, such as when floods displace large numbers of people. 

A number of for-profit entities, such as Co-Diagnostics Inc. (NASDAQ: CODX), are taking on this challenge and developing diagnostics that can be used at home and at points of care without compromising reliability. The infectious disease risk is growing as climate changes, and each stakeholder needs to do what they can to blunt the blow of the knock-on effects of climate change. 

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Systemic Challenges in US Health Care Push Cancer Patients to Fly to China

For decades, lots of American patients have been traveling to “fringe” countries like Turkey, Cuba…

17 hours ago

VERAXA Biotech AG (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy

VERAXA is developing antibody-based cancer therapies aimed at improving the therapeutic window of existing treatment…

18 hours ago

Earth Science Tech Inc.’s (ETST) Shareholders Approve Key Proposals in Annual Meeting

Earth Science Tech held its first annual meeting of stockholders, virtually, on August 31, 2026+…

2 days ago

Rising Rates of the Uninsured Could Affect Every American

As more Americans become underinsured or uninsured as a result of rising health insurance premiums and the several…

5 days ago

Regentis Biomaterials Ltd. (NYSE American: RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair

Researchers across the field, from Duke University to Mayo Clinic, are increasingly focused on restoring…

5 days ago

Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market

BioMedWire Editorial Coverage: Today's multiple sclerosis treatments can slow down disease progression, but none of them…

6 days ago